|
1
|
Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
|
Diabetes Care
|
2009
|
2.02
|
|
2
|
Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.
|
Diabetes
|
2009
|
1.43
|
|
3
|
Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes.
|
J Immunol
|
2011
|
1.20
|
|
4
|
Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.
|
Immunogenetics
|
2003
|
1.03
|
|
5
|
TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
|
Br J Haematol
|
2006
|
0.96
|
|
6
|
Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells.
|
Blood
|
2005
|
0.92
|
|
7
|
Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.
|
Comp Med
|
2012
|
0.86
|
|
8
|
Testing agents for prevention or reversal of type 1 diabetes in rodents.
|
PLoS One
|
2013
|
0.84
|
|
9
|
Retroviral transduction in fetal thymic organ culture.
|
Methods Mol Med
|
2005
|
0.80
|